+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management



Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management



Clinical Rheumatology 36(6): 1387-1393



Variability of the 10-year cardiovascular (CV) risk predicted by the Framingham Risk Score (FRS) using lipids, FRS using body mass index (BMI), Reynolds Risk Score (RRS), QRISK2, Extended Risk Score-Rheumatoid Arthritis (ERS-RA), and algorithm developed by the American College of Cardiology and the American Heart Association in 2013 (ACC/AHA 2013) according to the European League Against Rheumatism (EULAR) 2015/2016 update of its evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis (RA) has not been evaluated in Mexican mestizo patients. CV risk was predicted using six different risk calculators in 116 patients, aged 40-75, who fulfilled the ACR/EULAR 2010 classification criteria. Results were multiplied by 1.5 according to the EULAR 2015/2016 update. Global comparison of the risk predicted by all scales was done using the Friedman test, considering a P value of ≤0.05 as statistically significant. Individual comparison between the algorithms was made using the Wilcoxon signed-rank test, and a P value of ≤0.003 was considered statistically significant. All calculators showed to be different in the Friedman test (p ≤ 0.001). Median values of predicted 10-year CV risk were 11.02% (6.18-17.55) for FRS BMI; 8.47% (4.6-13.16) for FRS lipids; 5.55% (2.5-11.85) for QRISK2; 5% (3.1-8.65) for ERS-RA; 3.6% (1.5-9.3) for ACC/AHA 2013; and 1.5% (1.5-4.5) for RRS. ERS-RA showed no difference when compared against QRISK2 (p = 0.269). CV risk calculators showed variability among them and cannot be used indistinctly in RA-patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 059410381

Download citation: RISBibTeXText

PMID: 28150104

DOI: 10.1007/s10067-017-3551-7


Related references

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Annals of the Rheumatic Diseases 76(1): 17-28, 2016

Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index. Clinical Rheumatology 31(1): 35-39, 2012

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases 69(2): 325-331, 2010

Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index. Clinical and Experimental Rheumatology 32(2): 237-242, 2014

Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study. Annals of the Rheumatic Diseases 77(4): 625-626, 2017

FRI0147Screening for cardiovascular risk according to the eular recommendations in outpatients with rheumatoid arthritis reveals significant risk factors. Annals of the Rheumatic Diseases 72(Suppl 3): A420.1-A420, 2013

AB0339Stratification of Cardiovascular Risk by Framingham Score in a Mexican Mestizo Rheumatoid Arthritis Cohort. Annals of the Rheumatic Diseases 74(Suppl 2): 1007.1-1007, 2015

AB0340Carotid Intima-Media Thickness and Cardiovascular Risk by 4 Scores in a Mexican Mestizo Rheumatoid Arthritis Cohort. Annals of the Rheumatic Diseases 74(Suppl 2): 1007.2-1007, 2015

Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations. Annals of the Rheumatic Diseases 72(11): 1771-1776, 2013

Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care. Annals of the Rheumatic Diseases 77(4): 480-483, 2017

Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment. Bmc Rheumatology 2: 10, 2019

OP0257Rheumatoid Arthritis-Specific Cardiovascular Risk Calculators Are Not Superior To Risk Calculators Established for The General Population: A Validation Analysis in A Cohort of RA Patients from 7 Countries. Annals of the Rheumatic Diseases 75(Suppl 2): 155.2-155, 2016

Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Annals of the Rheumatic Diseases 70(5): 719-721, 2011

Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project. Rheumatology 56(9): 1472-1478, 2017

OP0314Is Cardiovascular Risk Management in Patients with Rheumatoid Arthritis Effective? Two Year Follow Up Reveals Unexpected Rise in Cardiovascular Risk!. Annals of the Rheumatic Diseases 74(Suppl 2): 192.1-192, 2015